Shares of Medtronic (NYSE: MDT) are off to a fantastic start in 2025, already rising by 13% year to date. The medical devices ...

The so-called 'hybrid closed-loop' system comprises a blood glucose sensor, the MiniMed 670G insulin pump and an infusion patch. Type 1 diabetes patients using the device will no longer have to ...

Insulin pump therapy, also known as continuous subcutaneous ... A.L.P. has been a consultant for Medtronic MiniMed and has received a grant from the Medtronic/MiniMed Foundation.

Roche is teaming up with two medical tech companies to develop an automated insulin delivery system, the first steps towards an ‘artificial pancreas.’ The Swiss pharma will work with existing ...

Graduate students whiz around this slimy beating heart and crawl under the tubes connected to the apparatus cradling the organ as a Medtronic scientist prods a snaking tool around its interior. This ...

Medtronic is a solid dividend-paying stock. Its stock recently yielded 3.2%. It has increased its payout for nearly 50 years in a row. If you're a dividend investor, I can understand why ...

Patients to pay no more than $35 a month Eli Lilly, Sanofi previously settled overcharging claims Novo Nordisk denies wrongdoing, pledges affordable insulin Jan 27 (Reuters) - Novo Nordisk (NOVOb ...

Minnesota Attorney General Keith Ellison on Monday announced a settlement in a lawsuit against insulin manufacturer Novo Nordisk. Minnesota residents will now be able to get Novo Nordisk insulin ...

One of the significant advancements in diabetes management is the use of insulin pump therapy, which provides a continuous supply of insulin to help maintain stable blood glucose levels.

The CDC’s primary medical journal for disseminating public health information went unpublished this week — seemingly for the first time ever — amid a communications freeze issued by HHS to ...

After hours: January 24 at 4:09:44 PM EST ...